- Brands
- Offerings
- Diagnostic Panels
- Knowledge Center
- Diagnostics
Core Laboratory
Core Laboratory
Webinars
Access on demand presentations led by subject matter experts and Abbott key opinion leaders to gain insight into industry trends, medical discoveries, healthcare technologies and much more.
WATCH NOW. VISIT US FREQUENTLY FOR NEW CONTENT.
SUCCESSFULLY MANAGING THE DEMANDS OF THE COVID-19 PEAKS
In this webinar, Deepak Mohan, MD, FCAP, FASCP, discusses the major challenges health systems are facing during this COVID-19 pandemic. He also presents on which diagnostic tools are providing valuable insights and what specific actions labs need to take today to help clinicians and patients.
Speaker
Deepak Mohan
Dr. Mohan is a pathologist in French Camp, CA. and is affiliated with San Joaquin General Hospital. He specializes in anatomic pathology and has been in practice for 16 years.
He received his medical degree from Sri Ramachandra Medical College and completed his Anatomic and Clinical Pathology Residency at University of Pittsburgh Medical Center and his Surgical Pathology Fellowship at Cedars-Sinai Medical Center, Los Angeles, CA.
SHORTENING THE TAIL OF THE COVID-19 CRISIS: STRATEGIES TO SHRINK THE TIMELINE OF THE PANDEMIC
In this webinar, Dr. Robert DeCresce, Director, Rush Medical Laboratories and Chair of Rush Health discusses how the role of the laboratorian has evolved during this crisis and the latest tools at their disposal. Dr. DeCresce also presents on the progression of testing from the original CDC test to the latest antibody testing that Rush University Medical Center is currently using to test their patients, employees and their communities.
Speaker
Dr. Robert DeCresce
Dr. Robert P. DeCresce, received his medical degree from Columbia University College of Physicians and Surgeons and specializes in clinical pathology. Dr. DeCresce is director of Rush Medical Laboratories and acting director of the Rush University Cancer Center. He served as president of the Rush medical staff and has been a member of the Rush University Medical Center Board of Trustees.
Original Event: April 28, 2020. Content, perspectives and studies shared within this webinar are based on knowledge known as of April 24, 2020.
CREATING CLINICAL ENGAGEMENT IN DISCRETE PANDEMIC PHASES
In this webinar, Dr. Laposata, is Professor and Chair of the Department of Pathology at the University of Texas Medical Branch-Galveston discusses the most commonly encountered factors that increase the risk of becoming infected and seriously ill with SARS-CoV-2 infection. He also discusses cross-reactivity between SARS-CoV-2 and other coronaviruses and the sensitivity of tests to detect active SARS-CoV-2 infection and Interpretation of PCR, IgM and IgG results.
Speaker
Dr. Laposata
Dr. Laposata, is Professor and Chair of the Department of Pathology at the University of Texas Medical Branch-Galveston. Dr. Laposata received his M.D. and Ph.D. from Johns Hopkins University School of Medicine and completed a postdoctoral research fellowship and residency in Laboratory Medicine (Clinical Pathology) at Washington University School of Medicine in St. Louis.
Original Event: May 5, 2020. Content, perspectives and studies shared within this webinar are based on knowledge known as of May 4, 2020.
IMPACT OF GLOBAL VIRAL SURVEILLANCE ON DIAGNOSTIC TOOLS
When disease-causing viruses (e.g. hepatitis B) mutate, there is a risk of being unable to detect them for diagnosis and monitoring, as well as the risk that the treatment response to current medications may be lessened. Therefore, viral genetic diversity has the potential to impact a vast number of healthcare touchpoints.
Abbott is constantly searching for new ways to improve people's health. A critical success factor involves monitoring retroviruses and hepatitis viruses from around the globe with a surveillance program, to help ensure laboratory tests continue to accurately detect divergent virsuses, regardless of where they are acquired. Since 1994, Abbott's Global Viral Surveillance Program has been at the forefront of viral surveillance continually evolving to impact the development of next generation solutions.
Speaker
Gavin A. Cloherty, PHD
Head of Infectious Disease Research, Abbott Diagnostics
Gavin A. Cloherty, graduated from the National University of Ireland, Galway, where he received his Ph.D in molecular biology and a Bachelor of Science in microbiology and zoology. He provides scientific leadership in the area of infectious disease diagnostics by leading groundbreaking clinical studies on hepatitis and HIV. As one of the top experts in the field, his innovative research is changing the way infectious diseases are being diagnosed to help improve patient outcomes.
Gavin has 20 years of experience with Abbott and leads a team of scientists in the study of HIV and hepatitis related discoveries, Gavin leads a team that recently identified unique hepatitis E recombinant strains in humans, uncovered unexpectedly high prevalence of hepatitis Delta in countries such as Cameroon, and identified strains of the newly discovered HPgV-2 in samples from around the world.
Throughout his career Gavin has published numerous abstracts, posters, and manuscripts. He has established numerous partnerships with commercial organizations, ministries of health and government agencies, including the Centers for Disease Control and Prevention (CDC). He is a member of numerous professional and scientific societies, including the International AIDS Society and the American Association for the Study of Liver Disease.
Gavin has 20 years of experience with Abbott and leads a team of scientists in the study of HIV and hepatitis related discoveries, Gavin leads a team that recently identified unique hepatitis E recombinant strains in humans, uncovered unexpectedly high prevalence of hepatitis Delta in countries such as Cameroon, and identified strains of the newly discovered HPgV-2 in samples from around the world.
Throughout his career Gavin has published numerous abstracts, posters, and manuscripts. He has established numerous partnerships with commercial organizations, ministries of health and government agencies, including the Centers for Disease Control and Prevention (CDC). He is a member of numerous professional and scientific societies, including the International AIDS Society and the American Association for the Study of Liver Disease.
LEARNING OBJECTIVES
- Understand the evolution of the Global Viral Surveillance Program and find out what's new
- Discover the impact of viral surveillance on past, present and future laboratory diagnostic tools
- Understand how you can get involved in the program
WHO SHOULD WATCH
- Laboratorians
- Clinicians
Explore
Build key laboratory competencies and explore topics from various disciplines with our learning guides.
Find the latest information in laboratory science, therapeutic areas and Abbott innovation.
Watch the webinar to hear from experts how you can realize the value within and beyond your laboratory walls with a TVO approach.